The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Jun. 13, 2022
Applicant:
Chemocentryx, Inc., San Carlos, CA (US);
Inventors:
Christopher Lange, Hayward, CA (US);
Viengkham Malathong, Mountain View, CA (US);
Darren J. McMurtrie, Vancouver, CA;
Sreenivas Punna, Sunnyvale, CA (US);
Rajinder Singh, Belmont, CA (US);
Ju Yang, Palo Alto, CA (US);
Penglie Zhang, Foster City, CA (US);
Assignee:
CHEMOCENTRYX, INC., Thousand Oaks, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/085 (2006.01); C07D 211/40 (2006.01); A61P 35/00 (2006.01); C07C 215/12 (2006.01); C07F 5/02 (2006.01); C07D 401/14 (2006.01); C07D 213/30 (2006.01); C07D 405/12 (2006.01); C07C 229/22 (2006.01); C07D 319/18 (2006.01); C07D 417/12 (2006.01); A61K 45/06 (2006.01); C07C 235/42 (2006.01); C07C 235/20 (2006.01); C07D 239/42 (2006.01); C07C 255/54 (2006.01); C07D 213/61 (2006.01); C07D 413/12 (2006.01); C07D 205/04 (2006.01); A61P 31/00 (2006.01); C07D 237/08 (2006.01); C07D 401/12 (2006.01); C07D 213/85 (2006.01); C07D 239/30 (2006.01); C07D 405/14 (2006.01); C07D 401/04 (2006.01); C07D 409/12 (2006.01); C07D 213/80 (2006.01); A61P 29/00 (2006.01); C07C 317/22 (2006.01); C07F 9/58 (2006.01); A61K 31/015 (2006.01); A61K 31/03 (2006.01); A61K 31/277 (2006.01); A61K 38/00 (2006.01); C07C 43/168 (2006.01); A61K 31/36 (2006.01); A61K 31/44 (2006.01); A61K 31/505 (2006.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 31/085 (2013.01); A61K 31/015 (2013.01); A61K 31/03 (2013.01); A61K 31/277 (2013.01); A61K 38/00 (2013.01); A61K 45/06 (2013.01); A61P 29/00 (2018.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C07C 43/168 (2013.01); C07C 215/12 (2013.01); C07C 229/22 (2013.01); C07C 235/20 (2013.01); C07C 235/42 (2013.01); C07C 255/54 (2013.01); C07C 317/22 (2013.01); C07D 205/04 (2013.01); C07D 211/40 (2013.01); C07D 213/30 (2013.01); C07D 213/61 (2013.01); C07D 213/80 (2013.01); C07D 213/85 (2013.01); C07D 237/08 (2013.01); C07D 239/30 (2013.01); C07D 239/42 (2013.01); C07D 319/18 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07F 5/025 (2013.01); C07F 9/58 (2013.01); A61K 31/36 (2013.01); A61K 31/44 (2013.01); A61K 31/505 (2013.01); A61K 47/34 (2013.01); C07C 2601/02 (2017.05); C07C 2602/08 (2017.05); Y02A 50/30 (2018.01);
Abstract
Compounds are provided that are useful as immunomodulators. The compounds have the following Formula (II):